Chemotherapy at the End of Life in Colon Cancer Patients

Rushabh H. Doshi, Khushi Kohli, Tenzin Dhondup, Kevin Zhang, Siona Mishra, Asher Shin, Bhav Jain, Thiruvengadam Muniraj, Edward Christopher Dee, Section of Digestive Diseases, Yale School of Medicine, New Haven, Harvard Medical School, Harvard University, Department of Neuroscience, Johns Hopkins University, Department of Radiation Oncology, Memorial Sloan Kettering, New York City, Department of Medicine, Stanford University School of Medicine

American Journal of Hospice and Palliative Medicine®

Published online on January 31, 2026

Abstract

American Journal of Hospice and Palliative Medicine®, Ahead of Print.
BackgroundChemotherapy at the end of life may not extend survival and can diminish quality of life. Understanding patterns of use is critical to ensuring equitable, patient-centered care.ObjectiveTo examine racial and ethnic disparities in chemotherapy ...